510(k) device
Endius Atavi System
Endius, Inc. · Arthroscope (HRX, Class II) · First FDA decision Jun 26, 2002, newest Jan 13, 2006Ligament, tendon and cartilage injuries
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
510(k) pathway
Device trials
0
Naming "Endius Atavi"
MAUDE reports
0
Brand "Endius Atavi", since 2015
PubMed studies
0
Mentioning "Endius Atavi"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Endius Atavi System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- ENDIUS ATAVI SYSTEM510(k)
K053267 · Decided Jan 13, 2006 · 51 days after receipt
Device type: Arthroscope (HRX) · Orthopedic Surgery
- ENDIUS ATAVI SYSTEM510(k)
K022199 · Decided Oct 2, 2002 · 89 days after receipt
Device type: Arthroscope (HRX) · Orthopedic Surgery
- ENDIUS ATAVI SYSTEM510(k)
K021748 · Decided Jun 26, 2002 · 29 days after receipt
Device type: Arthroscope (HRX) · Orthopedic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Endius Atavi", any status and sponsor, newest update first.
No registered device study names "Endius Atavi".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Endius Atavi", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code HRX
18,629 reports: 17,308 malfunction, 1,310 injury, 2 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1045-2013 · Started Feb 8, 2013 · Posted by FDA Apr 1, 2013
Reason given: Possibility that the inner pouch may be compromised. The product is packaged in two pouches - a sterile inner pouch within an external pouch. NexPosure Retractors contained in a breached inner pouch have an increased risk of contamination (i.e.; loss of product sterility) if proper aseptic technique is not followed...
Cause as FDA categorized it: Package design/selection · Device type: Arthroscope (HRX)
Published research
The most relevant PubMed records for "Endius Atavi"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code HRX.
- SmartRelease Endoscopic Soft Tissue Release SystemMicroaire Surgical Instruments · 510(k) 2023
- Espin SystemNlt Spine, Ltd. · 510(k) 2013
- Spinevu Endoscopic Spine System (Sess)Spine View, Inc. · 510(k) 2012
- Sky Bone Expander System (Sky System)Disc-O-Tech Medical Technologies, Ltd. · 510(k) 2004
- Digital ClarusScope System and Digital NeuroPEN SystemClarus Medical, LLC · 510(k) 2026
- Arthrex Spine EndoscopeArthrex, Inc. · 510(k) 2025
- CORUS Spinal System-XProvidence Medical Technology, Inc. · 510(k) 2021
- Voyant SystemViseon, Inc. · 510(k) 2019
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.